Botulinum toxin A for nonambulatory children with cerebral palsy

04/22/2014 | Journal of Pediatrics, The

Children with the most severe forms of cerebral palsy (CP) are nonambulant, are unable to sit independently, and require significant assistance for daily activities (one-third of children with CP). In this randomized controlled trial, nonambulant children with CP (n = 41; mean age 7.1 years) were randomly allocated to receive either intramuscular botulinum toxin A injections (BoNT-A; n = 23) or sham procedure (n = 18) combined with therapy. Although there was no increase in moderate and severe adverse events in the children who had BoNT-A injections compared with the sham group, BoNT-A and therapy were effective for improving ease of care and comfort for nonambulant children with CP.

View Full Article in:

Journal of Pediatrics, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL